These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3062900)

  • 41. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The use of adrenal cortex hormones in rheumatic diseases of the nervous system and collagenoses in the neurological clinic (Review of the literature)].
    Man'kovskiĭ NB; Kazakevich RL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(7):1096-101. PubMed ID: 4299670
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship of the dosage form of a corticosteroid to its therapeutic efficacy.
    Coppoc GL
    J Am Vet Med Assoc; 1984 Nov; 185(10):1098-101. PubMed ID: 6210282
    [No Abstract]   [Full Text] [Related]  

  • 44. Corticosteroid replacement in critically ill patients.
    Jacobi J
    Crit Care Clin; 2006 Apr; 22(2):245-53, vi. PubMed ID: 16677998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corticosteroid therapy.
    Postgrad Med; 1971 Mar; 49(3):239-40. PubMed ID: 5547904
    [No Abstract]   [Full Text] [Related]  

  • 46. [Approach to the patient with eosinophilia].
    Olshtain-Pops K
    Harefuah; 2009 Jan; 148(1):36-8. PubMed ID: 19320388
    [No Abstract]   [Full Text] [Related]  

  • 47. [Current status of corticotherapy].
    Lyon Med; 1971 Oct; 226(16):411-28. PubMed ID: 5123732
    [No Abstract]   [Full Text] [Related]  

  • 48. Connective tissue diseases. Goals and strategies of management.
    Lockshin MD
    Postgrad Med; 1986 Aug; 80(2):193-8. PubMed ID: 3737494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Corticosteroid therapy. I. Pharmacological properties and principles of corticosteroid use.
    Streeten DH
    JAMA; 1975 Jun; 232(9):944-7. PubMed ID: 1173635
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diffuse interstitial lung disease and connective tissue diseases: study of seven cases in Dakar].
    Diallo S; Dia D; Fall S; Kâne A; Sané M; Thiam M; Pouye A; Mbaye PS; Kâ MM; Moréira-Diop T
    Dakar Med; 2008; 53(3):255-9. PubMed ID: 19626799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Interstitial lung disease related to systemic connective tissue diseases].
    Fiedorczyk M; Rojewska J; Kowal-Bielecka O; Sierakowski S
    Przegl Lek; 2005; 62(12):1471-4. PubMed ID: 16786776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of immunosuppressive agents in the therapy of systemic connective tissue disorders].
    Berović Z
    Reumatizam; 1972; 19(6):217-20. PubMed ID: 4657801
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pulsed methylprednisolone therapy of patients with systemic connective tissue diseases and rheumatoid arthritis].
    Kŭnev K; Bekiarova P; Dimitrova D
    Vutr Boles; 1988; 27(5):70-2. PubMed ID: 3213041
    [No Abstract]   [Full Text] [Related]  

  • 54. Corticosteroids and the eye. Preface.
    Schwartz B
    Int Ophthalmol Clin; 1966; 6(4):vii-ix. PubMed ID: 5989069
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapy for connective tissue disease.
    Smith EA; Leroy EC
    Compr Ther; 1986 Sep; 12(9):24-9. PubMed ID: 3769420
    [No Abstract]   [Full Text] [Related]  

  • 56. [Current trends in research on diffuse connective tissue diseases].
    Nasonova VA
    Vutr Boles; 1988; 27(5):50-6. PubMed ID: 3213039
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
    Shcherbakov AB
    Vutr Boles; 1988; 27(6):55-8. PubMed ID: 3247706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The selection of adrenocorticosteroid preparations.
    Kreines K; Weinberg IC
    Ohio State Med J; 1975 Oct; 71(14):698, 703-6. PubMed ID: 52855
    [No Abstract]   [Full Text] [Related]  

  • 59. [Substitution of the adrenal cortex hypofunction].
    Karl HJ
    Internist (Berl); 1967 Mar; 8(3):102-11. PubMed ID: 4870594
    [No Abstract]   [Full Text] [Related]  

  • 60. The catch-22 of limited Food and Drug Administration approval for connective tissue disease therapies.
    Min MS; Kassamali B; Mazori DR; Vleugels RA; Merola JF; Cobos G; LaChance AH
    J Am Acad Dermatol; 2021 Aug; 85(2):517-519. PubMed ID: 33823201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.